key: cord-0910055-v0kaefmw
authors: Angelika, Dina; Etika, Risa; Kusumawardani, Naomi Nathania; Mithra, Setya; Ugrasena, I Dewa Gede
title: Observational study on necrotizing enterocolitis in neonates born to SARS-CoV-2-positive mothers
date: 2022-05-06
journal: Ann Med Surg (Lond)
DOI: 10.1016/j.amsu.2022.103711
sha: 894b6383f131de662aadf8d9d1ca2369845327cf
doc_id: 910055
cord_uid: v0kaefmw

BACKGROUND: The impact of the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) pandemic on expectant mother and their babies extends to many aspects of life. Necrotizing enterocolitis (NEC) has been recognized as a life-threatening gastrointestinal inflammatory process in neonates that has high rates of morbidity and mortality. OBJECTIVE: To investigate factors associated with NEC in hospitalized neonates whose mothers were SARS-CoV-2-positive and their relationship to mortality. METHOD: This observational study was conducted from May 2020 to March 2021. All neonates who were hospitalized, after confirming that the mother was SARS-CoV-2-positive, were included in this study. The confirmation of positive SARS-CoV-2 was determined according to the reverse transcription-polymerase chain reaction (PCR) assay. The neonatal SARS-CoV-2 test was performed on the first day of birth. NEC was established based on a suggestive clinical presentation and abnormal abdominal radiographs. RESULTS: Of the 125 neonates enrolled in this study, there were 5 neonates who developed NEC and only one survived. Significant associated factors with NEC included lower birth weight (p < 0.001), lower gestational age (p < 0.001), positive SARS-CoV-2 PCR results (OR = 15.333; 95% CI = 2.074–113.381, p = 0.007), asphyxia (OR = 13.143; 95% CI = 1.411–122.443, p = 0.024), and mortality (OR = 156.000; 95% CI = 13.157–1849.623; p < 0.001). Mortality was significantly associated with lower gestational age (p = 0.025), cesarean section delivery (p = 0.025), and asphyxia (p = 0.025). CONCLUSION: Significant associated factors with NEC in neonates born to SARS-CoV-2-positive mothers included positive SARS-CoV-2 PCR results, asphyxia, lower gestational age, and lower birth weight. In addition to caesarean section delivery, these factors were related to mortality in neonates in such conditions.

The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) epidemic started 7 in China and quickly disseminated to other countries and has become a major global health 8 problem since then. As it has been labeled as a global pandemic in 2019, many expectant 9 mothers and their babies have experienced serious health problems due to SARS-CoV-2, 10 including expectant mothers and babies in Indonesia [1] . The government of Indonesia 11 reported that the confirmed case in Indonesia has reached 6 million positive cases with a total 12 of more than 155,000 deaths [2] . When second-wave cases were identified, the prevalence of 13 SARS-CoV-2 cases in Indonesia grew rapidly, with the average number of new confirmed 14 around 4,000-5,000/day [3] . Based on the Indonesian Obstetrics Doctors Association (POGI) 15 reports as of April 2021, there have been more than 500 cases of SARS-CoV-2 infected 16 expectant mothers, 16 of whom died [4] .

Necrotizing enterocolitis (NEC) has been recognized as a terrible inflammation of the 1 gastrointestinal tract in neonates that often requires surgery. The contribution of NEC to 2 neonatal morbidity and mortality is still high, particularly in developing countries. Surviving 3 NEC infants may have poor growth and neurodevelopmental impairment [6] . Previous 4 studies identified the incidence of NEC in preterm infants born to mothers with COVID-19 5 which correlated with the condition of the mother experiencing respiratory distress during 6 delivery, asphyxia, and positive PCR results for infants [7] . However, the role of SARS-CoV-7 2 infections in expectant mothers on the incidence of NEC in their infants, regardless of 8 gestational age or birth weight, has not been well established. Thus, this study aimed to find 9 out the factors associated with NEC in hospitalized neonates whose mothers were SARS-10 CoV-2-positive and to investigate whether these factors were associated with mortality in 11 such conditions. 12 13

This study was conducted from May 2020 to March 2021. All neonates who were 16 hospitalized, after confirming that his/her mother was SARS-CoV-2-positive, were included 17 in this study. Neonates born outside the hospital were not included in this study. This hospital In cases which the SARS-CoV-2 virus could be detected on a nose and throat swab 23 through the reverse transcription-polymerase chain reaction (RT-PCR) assay, the case was 24 then declared positive. The laboratory appointed to carry out the RT-PCR examination was an official laboratory established by the Government of Indonesia based on the Decree of the Care for neonates born to SARS-CoV-2-positive mothers 17 An expectant mother who was confirmed positive for SARS-CoV-2 was cared for in a 18 separate treatment room and monitored by a team of doctors dedicated to treating SARS-

CoV-2 disease. The delivery was deployed in a separate room specifically for SARS-CoV-2-20 positive patients, including the operating room which also used the SARS-CoV-2 operating 21 room. At the time of delivery, the neonatal doctor team had been notified and had been 22 present before delivery occurred. Neonates born either spontaneously or by cesarean section 23 would be treated in the SARS-CoV-2 neonatal care room. Enteral nutrition was given using 24 expressed breast milk or formula with the consent of the mother or the neonate's family. The RT-PCR examination of the neonate was performed within 24 hours after birth. If the 1 neonate's RT-PCR result was negative, the neonate could be transferred to a non-SARS-CoV-2 2-positive neonatal care room. The SARS-CoV-2-negative neonate could be cared for with 3 the mother if the mother's RT-PCR result was negative. In this study, neonates were observed 4 until the neonate was discharged from the hospital or until he/she died. Only mothers with positive SARS-CoV-2 were analyzed in this study. Variables were 8 collected including neonatal factors (gestational age, birth weight, sex, mode of delivery, 9 SARS-CoV-2 PCR swab result, asphyxia, multiple births, NEC, mortality) and maternal 10 comorbidities (obesity, pre-eclampsia, hypertension, premature rupture of membranes, 11 hepatitis B, placenta accrete) were selected as the variables analyzed in this study. Asphyxia 12 is failure to establish adequate breathing at birth defined as a fifth-minute Apgar score of less 13 than 7 [10]. Multiple births were confirmed when the mother gave birth to more than one 14 baby in one delivery [11] . Data on neonates and maternal comorbidities were obtained from 15 medical records. We also interviewed the mother to obtain information related to the mother's 16 medical record, including the provision of feeding. The study report is based on Qualitative data were presented using numbers and percentages. Quantitative data were 21 performed in terms of mean, minimum, maximum, and standard deviation. In this study, 22 statistical analysis of the chi-squared and logistic regression tests was used. To predict the 23 independent variable (sex, mode of delivery, SARS-CoV-2 RT-PCR result, asphyxia, 24 mortality) to the dependent variable (necrotizing enterocolitis), this study used a logistic regression test. The chi-squared test was used to analyze selected variables (sex, birth weight, 1 gestational age, mode of delivery, SARS-CoV-2 RT-PCR result, and asphyxia) with mortality 2 in NEC neonates. Statistical analyses were interpreted using IBM SPSS Statistics 21 (IBM 3 Corp., Armonk, NY, USA); this included descriptive and inferential analyses. A p-value 4 <0.05 was considered significant. parent who did not provide consent, then there were 125 neonates who were included in the 10 final analysis. The minimum birth weight was 1000 g and the maximum birth weight was 11 4300 g (2867.60 ± 698.75), meanwhile the minimum gestational age was 28 weeks and the 12 maximum gestational age was 41 weeks (37.05 ± 2.81). In this study, the majority of Table 1 . 

In this study, 5 neonates experienced NEC and only 1 survived. Most neonates with 22 NEC were female (60%). All cases of NEC occurred at a lower gestational age (<37 weeks) 23 and lower birth weight (<2500 g). Based on the distribution of birth weight and gestational 24 age groups, in the group of neonates with NEC, as many as 3 (60%) neonates had a birth weight of 1500-2499 grams and as many as 4 (80%) had a gestational age of <34 weeks. 1 Most of the neonates (60%) had negative RT-PCR results and as many as 4 (80%) infants had 2 a history of asphyxia at birth. 3 There were significant differences in gestational age (p <0.001), birth weight (p 4 <0.001), positive RT-PCR results (p = 0.007), history of asphyxia (p = 0.024), and mortality 5 (p <0.001) between neonates with NEC and neonates without NEC. Meanwhile, there were 6 no significant differences in sex (p = 0.469) and mode of delivery (p = 0.422) between 7 neonates with NEC and neonates without NEC ( Table 2) . Table 2 . Table 3 . pregnancy termination must be carried out. The condition of severe respiratory distress in an 9 expectant mother will have a detrimental impact on the baby so that it contributes to the baby 10 being born with asphyxia [1] . Other than those maternal antenatal factors, there was also the 11 nutritional factor that should be taken into consideration regarding the incidence of NEC in 12 neonates of SARS-CoV-2-positive mothers. As it has been known, breastmilk is one of the 13 most effective ways to prevent NEC. Though coronavirus hasn't been detected in breast milk, The diagnosis of NEC is challenging because the symptoms may go unnoticed by the 21 clinician even though it is progressive and causes high mortality. Intestinal fatty acid-binding 22 protein (I-FABP) has good accuracy in early detection and predicting the severity of NEC 23 with a sensitivity of 90% and a specificity of 100% [30] . In this study, the diagnosis of NEC 24 was based on clinical symptoms that support NEC and abnormal abdominal radiographs. In our country, the I-FABP examination is not always available and is not easy to obtain. 1 Abdominal ultrasonography (USG) has recently been used as a diagnostic imaging option in 2 NEC because abdominal USG has a good ability to detect intestinal peristalsis, bowel wall 

Name of the registry: Health Research Ethics Coommitee in the Dr

Unique Identifying number or registration

Hyperlink to your specific registration

The following information is required for submission. Please note that failure to respond to these questions/statements will mean your submission will be returned. If you have nothing to declare in any of these categories then this should be stated.

All authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.Dina Angelika, Risa Etika, Naomi Nathania Kusumawardani, Setya Mithra, and I Dewa Gede Ugrasena declare that they have no conflict of interest.

All sources of funding should be declared as an acknowledgement at the end of the text. Authors should declare the role of study sponsors, if any, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. If the study sponsors had no such involvement, the authors should so state.

Research studies involving patients require ethical approval. Please state whether approval has been given, name the relevant ethics committee and the state the reference number for their judgement. Authors must obtain written and signed consent to publish a case report from the patient (or, where applicable, the patient's guardian or next of kin) prior to submission. We ask Authors to confirm as part of the submission process that such consent has been obtained, and the manuscript must include a statement to this effect in a consent section at the end of the manuscript, as follows: "Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request".Patients have a right to privacy. Patients' and volunteers' names, initials, or hospital numbers should not be used. Images of patients or volunteers should not be used unless the information is essential for scientific purposes and explicit permission has been given as part of the consent. If such consent is made subject to any conditions, the Editor in Chief must be made aware of all such conditions.Even where consent has been given, identifying details should be omitted if they are not essential. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.Written informed consent was obtained from the patient.

Please specify the contribution of each author to the paper, e.g. study concept or design, data collection, data analysis or interpretation, writing the paper, others, who have contributed in other ways should be listed as contributors.All authors contributed toward data analysis, drafting and revising the paper, gave final approval of the version to be published and agree to be accountable for all aspects of the work.

In accordance with the Declaration of Helsinki 2013, all research involving human participants has to be registered in a publicly accessible database. Please enter the name of the registry and the unique identifying number (UIN) of your study.You can register any type of research at http://www.researchregistry.com to obtain your UIN if you have not already registered. This is mandatory for human studies only. Trials and certain observational research can also be registered elsewhere such as: ClinicalTrials.gov or ISRCTN or numerous other registries.